ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report) shares dropped 20.1% on Tuesday . The stock traded as low as $32.47 and last traded at $32.47. Approximately 917 shares were traded during trading, an increase of 75% from the average session volume of 525 shares. The stock had previously closed at $40.65.
ALK-Abelló A/S Stock Performance
The business’s 50 day moving average price is $37.89 and its 200-day moving average price is $36.35.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Articles
- Five stocks we like better than ALK-Abelló A/S
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
